NVO241122C91000
- 0.00
- 0.000.00%
Novo-Nordisk A/S Newsroom
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.
Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.
Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know
Weight-loss Drugmakers' Stocks Get a Boost From New Biden Proposal on Drug Coverage, but Will It Hold Up?
Today's Pre-Market Movers and Top Ratings | PSTX, LLY, KSS, BBY and More
Novo Nordisk and Eli Lilly Shares Are Trading Higher After the Biden-Harris Administration Proposed a New Step to Expand Coverage of Anti-obesity Medications for Medicare and Medicaid Beneficiaries.
Amgen Posts Mid-stage Data for Weight Loss Therapy
Update: Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
Novo Nordisk's earnings in the first three quarters saw a significant increase of 76% year-on-year, with weight loss becoming a growth engine for novo-nordisk a/s.
This century-old pharmaceutical company is attracting the attention of global investors with its groundbreaking achievements in the field of obesity treatment.
"Norel" welcomes a heavyweight bullish news! It is rumored that weight loss drugs are expected to enter the US medical insurance system.
According to reports, the government led by usa President Biden is proposing a regulation that would require payment for weight loss drugs, potentially expanding access to these medications for millions of obese americans and creating a massive new medical bill for elected President Donald Trump.
Novo Nordisk Shares Higher on White House Plans to Extend Obesity Drug Coverage -- Market Talk
Drug Compounders Fight Drugmaker Efforts to Push Them Out of Market for GLP-1 Medications
Trump's Made His Health Picks. What They Mean for the Sector. -- Barrons.com
Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick
Novo Nordisk Foundation Targets US, Europe After Obesity Boost
Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover
Novo Holdings to Acquire Benchmark Genetics, a Leader in Aquaculture Genetics
Weekend news: The total amount of usa national debt exceeds 36 trillion dollars. Anthropic receives another 4 billion dollar investment from amazon. Tesla and Rivian reach a conditional settlement.
For more global financial news, please visit 24/7 real-time financial news. Market review last week: The Dow rose over 400 points to a new high, with all three major stock indexes recording gains for the week. On November 22, the top 20 US stock turnover includes reports that Tesla is preparing for the Cybertruck to enter the Chinese market. Popular China concept stocks had mixed performance on Friday, with Wanxiang Reburn increasing by 9.2% and pdd holdings falling by 3.9%. US WTI crude oil rose 6.5% this week, escalating tensions between Russia and Ukraine driving up oil prices. Spot gold rose 5.7% in five days, regaining the $2,700 level. European stocks collectively closed higher, with the German DAX 30 index rising by 0.8%.
Are Hedge Funds Betting Big on Novo Nordisk (NVO)'s Diabetes and Chronic Disease Care?